Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Editas Medicine, Inc. (EDIT)
| Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/11/2023 | Eaton Bruce | EVP, CBO AND CTO | Sale | Common Stock | 702 | $8.59 | $6k | | 08/11/2023 |
| 08/08/2023 | Eaton Bruce | EVP, CBO AND CTO | Sale | Common Stock | 141 | $8.39 | $1.2k | | 08/08/2023 |
| 06/05/2023 | Eaton Bruce | EVP, CBO AND CTO | Sale | Common Stock | 105 | $9.50 | $997.8 | | 06/05/2023 |
| 06/05/2023 | O'Neill Gilmore Neil | CEO | Sale | Common Stock | 6.5k | $9.50 | $61.6k | | 06/05/2023 |
| 05/17/2023 | Lucera Erick | EVP, CFO | Grant | | 77.9k | $0.00 | $0 | | 05/17/2023 |
| 05/17/2023 | Lucera Erick | EVP, CFO | Grant | Stock Option (right to buy) | 155.8k | $9.61 | $1.5M | | 05/17/2023 |
| 05/11/2023 | Eaton Bruce | EVP, CBO AND CTO | Sale | Common Stock | 668 | $9.87 | $6.6k | | 05/11/2023 |
| 05/11/2023 | ROBERTSON MICHELLE | EVP, CFO | Sale | Common Stock | 949 | $9.87 | $9.4k | | 05/11/2023 |
| 05/09/2023 | Eaton Bruce | EVP, CBO AND CTO | Sale | Common Stock | 135 | $9.51 | $1.3k | | 05/09/2023 |
| 03/03/2023 | Eaton Bruce | EVP, CBO AND CTO | Sale | Common Stock | 101 | $8.89 | $897.9 | | 03/02/2023 |
| 03/03/2023 | ROBERTSON MICHELLE | EVP, CFO | Sale | Common Stock | 184 | $8.89 | $1.6k | | 03/02/2023 |
| 03/02/2023 | ROBERTSON MICHELLE | EVP, CFO | Grant | Stock Option (right to buy) | 94.5k | $8.72 | $824k | | 03/02/2023 |
| 03/02/2023 | ROBERTSON MICHELLE | EVP, CFO | Grant | | 31.5k | $0.00 | $0 | | 03/02/2023 |
| 03/02/2023 | Eaton Bruce | EVP, CBO AND CTO | Grant | Stock Option (right to buy) | 50k | $8.72 | $436k | | 03/02/2023 |
| 03/02/2023 | Eaton Bruce | EVP, CBO AND CTO | Grant | | 16.7k | $0.00 | $0 | | 03/02/2023 |
| 03/02/2023 | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | Grant | | 18k | $0.00 | $0 | | 03/02/2023 |
| 03/02/2023 | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | Grant | Stock Option (right to buy) | 54k | $8.72 | $470.9k | | 03/02/2023 |
| 03/02/2023 | O'Neill Gilmore Neil | CEO | Grant | Stock Option (right to buy) | 150k | $8.72 | $1.3M | | 03/02/2023 |
| 03/02/2023 | O'Neill Gilmore Neil | CEO | Grant | | 50k | $0.00 | $0 | | 03/02/2023 |
| 02/07/2023 | Eaton Bruce | EVP, CBO AND CTO | Sale | Common Stock | 346 | $11.10 | $3.8k | | 02/07/2023 |
| 01/10/2023 | ROBERTSON MICHELLE | EVP, CFO | Sale | Common Stock | 1.8k | $8.16 | $14.3k | | 01/10/2023 |
| 12/05/2022 | ROBERTSON MICHELLE | EVP, CFO | Sale | Common Stock | 193 | $10.23 | $2k | | 12/05/2022 |
| 12/05/2022 | Eaton Bruce | EVP, CBO AND CTO | Sale | Common Stock | 102 | $10.23 | $1k | | 12/05/2022 |
| 11/08/2022 | Eaton Bruce | EVP, CBO AND CTO | Sale | Common Stock | 289 | $11.02 | $3.2k | | 11/08/2022 |
| 09/06/2022 | ROBERTSON MICHELLE | EVP, CFO | Sale | Common Stock | 192 | $15.01 | $2.9k | | 09/06/2022 |
| 09/06/2022 | Eaton Bruce | EVP, CBO AND CTO | Sale | Common Stock | 101 | $15.01 | $1.5k | | 09/06/2022 |
| 08/09/2022 | Eaton Bruce | EVP, CBO AND CTO | Sale | Common Stock | 293 | $18.60 | $5.4k | | 08/09/2022 |
| 07/18/2022 | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | Grant | Stock Option (right to buy) | 171.6k | $14.99 | $2.6M | | 07/18/2022 |
| 07/18/2022 | Mei Baisong | SVP, CHIEF MEDICAL OFFICER | Grant | | 58.4k | $0.00 | $0 | | 07/18/2022 |
| 06/15/2022 | Shearman Mark S | EVP, CHIEF SCIENTIFIC OFFICER | Sale | Common Stock | 5.1k | $10.06 | $51.7k | | 06/15/2022 |
| 06/09/2022 | Hirsch Andrew | Director | Grant | Stock Option (right to buy) | 25k | $12.31 | $307.8k | | 06/09/2022 |
| 06/09/2022 | Hopfield Jessica | Director | Grant | Stock Option (right to buy) | 25k | $12.31 | $307.8k | | 06/09/2022 |
| 06/09/2022 | Vaishnaw Akshay | Director | Grant | Stock Option (right to buy) | 25k | $12.31 | $307.8k | | 06/09/2022 |
| 06/09/2022 | Scadden David | Director | Grant | Stock Option (right to buy) | 25k | $12.31 | $307.8k | | 06/09/2022 |
| 06/09/2022 | Reeve Emma | Director | Grant | Stock Option (right to buy) | 25k | $12.31 | $307.8k | | 06/09/2022 |
|
|